Pegasystems director awarded 3,868 shares, options

PEGASYSTEMS INC (PEGA) director Sharon T. Rowlands reported equity awards for board service.

Rhea-AI Filing Summary

PEGASYSTEMS INC (PEGA) director Sharon T. Rowlands reported equity awards for board service. On 2026-08-15, she received 3,868 shares of unrestricted common stock as consideration for her annual director term. The same day, she was granted a non-statutory stock option for 7,947 shares of common stock, fully vested on issuance, with an exercise price of $32.32 per share and an expiration date of 2036-08-15. Following these awards, she directly holds 3,868 common shares and the reported option, and indirectly holds 67,730 common shares through the “Sharon T. Rowlands Living Trust u/a/d 01/03/2020.”

Insider Trade Summary

Grant/Award: 11,815 shares

Grant/Award 3 txns

Insider Rowlands Sharon T

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options F2	7,947	$0.00	$0.00
Grant/Award	Common stock F1	3,868	$0.00	$0.00
holding	Common stock	--	--	--

Holdings After Transaction: Stock Options — 7,947 contracts (Direct); Common stock — 3,868 shares (Direct); Common stock — 67,730 shares (Indirect, Sharon T. Rowlands Living Trust u/a/d 01/03/2020)

Footnotes (2)

1. F1. Represents shares of unrestricted common stock received as consideration for the reporting person's service as a Director for the annual term.
2. F2. Non-statutory stock option fully vested on issuance and granted as consideration for the reporting person's services as a Director for the annual term.

Key Figures

Unrestricted stock grant: 3,868 shares Stock option grant size: 7,947 shares Option exercise price: $32.32 per share +3 more

6 metrics

Unrestricted stock grant 3,868 shares Common stock received as director compensation on 2026-08-15

Stock option grant size 7,947 shares Non-statutory stock option granted on 2026-08-15

Option exercise price $32.32 per share Exercise price for the stock option granted 2026-08-15

Option expiration date 2036-08-15 Expiration of the non-statutory stock option

Direct shares after grant 3,868 shares Total directly held common stock following reported transactions

Indirect trust holdings 67,730 shares Common stock held via Sharon T. Rowlands Living Trust u/a/d 01/03/2020

Key Terms

Non-statutory stock option, unrestricted common stock, exercise price, indirect

4 terms

Non-statutory stock option financial

"Non-statutory stock option fully vested on issuance and granted as consideration"

A non-statutory stock option is a company-granted right that lets a person buy shares later at a set price but does not receive special tax-favored treatment under tax law. It matters to investors because when the option is used the holder usually pays ordinary income tax on the gain and the company records compensation cost and issues new shares, which can reduce existing owners’ percentage ownership—think of it like a coupon to buy stock that creates a taxable event and some dilution.

unrestricted common stock financial

"Represents shares of unrestricted common stock received as consideration"

exercise price financial

"conversion_or_exercise_price": "32.3200""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

indirect financial

"ownership_type": "indirect""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did PEGA director Sharon T. Rowlands receive on 2026-08-15?

Sharon T. Rowlands received 3,868 shares of unrestricted PEGA common stock and a fully vested stock option for 7,947 shares as consideration for her annual director service term.

What are the key terms of Sharon T. Rowlands’ new PEGA stock option?

The non-statutory stock option covers 7,947 shares of PEGA common stock, has an exercise price of $32.32 per share, fully vested on issuance, and carries an expiration date of 2036-08-15.

How many PEGA common shares does Sharon T. Rowlands now hold directly?

After the reported grant, Sharon T. Rowlands directly holds 3,868 shares of PEGA common stock, representing unrestricted stock received as compensation for her service as a director for the annual term.

What indirect PEGA share holdings does Sharon T. Rowlands report?

Sharon T. Rowlands reports 67,730 shares of PEGA common stock held indirectly through the “Sharon T. Rowlands Living Trust u/a/d 01/03/2020”, reflecting trust-held ownership rather than direct personal registration.

Was Sharon T. Rowlands’ PEGA Form 4 filed under a Rule 10b5-1 plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not selected (aff_10b5_one is false), and the footnotes describe the awards as consideration for director service rather than transactions under a trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2026 - 04:33 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rowlands Sharon T

(Last) (First) (Middle)

C/O PEGASYSTEMS INC

225 WYMAN STREET, STE 300

(Street)

WALTHAM MASSACHUSETTS 02451

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PEGASYSTEMS INC [ PEGA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	08/15/2026		A		3,868(1)	A	$0	3,868	D
Common stock								67,730	I	Sharon T. Rowlands Living Trust u/a/d 01/03/2020

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$32.32	08/15/2026		A		7,947(2)		08/15/2026	08/15/2036	Common stock	7,947	$0	7,947	D

Explanation of Responses:

1. Represents shares of unrestricted common stock received as consideration for the reporting person's service as a Director for the annual term.

2. Non-statutory stock option fully vested on issuance and granted as consideration for the reporting person's services as a Director for the annual term.

Remarks:

	/s/ Ewelina Kemp, Attorney-in-Fact for Sharon T. Rowlands	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)